INTRODUCTION
In this presentation, current and advanced neuroimaging technologies are discussed along with guidelines for utilization and principles of imaging diagnosis in fetal, perinatal, and neonatal brain abnormalities. This includes pattern of injury and timing issues with special emphasis on neurovascular diseases and differential diagnosis. In the causative differentiation of static encephalopathies (e.g., cerebral palsy Ð CP) from progressive encephalopathies, specific disease categories and gestational timing are addressed (Table 1) . These include developmental abnormalities, trauma, neurovascular disease, infections and inflammatory processes, and metabolic disorders. Although a rare but important cause of progressive perinatal encephalopathy, neoplastic processes are not considered in detail here.
NEUROIMAGING TECHNOLOGIES AND GENERAL UTILIZATION
Imaging modalities may be classified as structural or functional. 1 ± 4 Structural imaging modalities provide spatial resolution based primarily on anatomic or morphologic data. Functional imaging modalities provide spatial resolution based upon physiologic or metabolic data. Some modalities may actually be considered to provide both structural and functional information. Ultrasonography (US) is primarily a structural imaging modality with some functional capabilities (e.g., Doppler Ð Figure 1 ). 1 ± 11 It is readily accessible, portable, fast, real time and multiplanar. It less expensive than other cross-sectional modalities and relatively noninvasive (nonionizing radiation). It requires no contrast agent and infrequently needs patient sedation. The resolving power of US is based on variations in acoustic reflectance of tissues. Its diagnostic effectiveness, however, is primarily dependent upon the skill and experience of the operator and interpreter. Also, US requires a window or path unimpeded by bone or air for cranial and spinal imaging. Probably the most important uses of US are (1) fetal and neonatal screening, (2) screening of the infant who cannot be examined in the radiology department (e.g., premature neonate with intracranial hemorrhage, ECMO, intraoperative), (3) when important adjunctive information is quickly needed (e.g., cystic versus solid, vascularity, vascular flow, e.g., Doppler Ð see Figure 1 , or increased intracranial pressure), and (3) for real-time guidance and monitoring of invasive diagnostic or therapeutic surgical and interventional procedures.
In the last few years, advances in US techniques have continued to improve at a dramatic pace. 1 ± 11 The development of high-resolution transducers, improvements in color Doppler signal processing, and new scanning techniques have significantly improved our ability to visualize structural and vascular abnormalities in the neonatal brain. Examples are the mastoid view to better visualize the posterior fossa, power Doppler and transcranial Doppler (TCD) to evaluate intracranial hemodynamics [e.g., resistive indices (RI) Ð see Figure 1 ], and the graded fontanelle compression Doppler technique to evaluate hydrocephalus. Another recent advance in US technology is the development of vascular US contrast agents to amplify reflected sound waves. Potential applications include the detection of slow flow and the assessment of organ perfusion. Increased sensitivity and specificity also may soon be provided by advances in computerized analysis of textural features.
Computed tomography (CT) is also primarily a structural imaging modality that has some functional capabilities (e.g., CT angiography). or sagittal) is the alternative. Projection scout images may provide information similar to plain films but with less spatial resolution. CT of the pediatric CNS is usually done using either the conventional or the helical/spiral technique. CT requires sedation in infants and young children more often than does US but less often than MRI. The neonate or very young infant, however, may be examined while asleep after a feeding or during a nap. CT occasionally needs intravenous iodinated contrast enhancement, and sometimes cerebrospinal (CSF) contrast opacification. High-resolution bone and soft-tissue algorithms are important for demonstrating fine anatomy (e.g., skull base). Advances in computer-display technology include image fusion, two-dimensional reformatting, three-dimensional volumetric and reconstruction methods, segmentation, and surface-rendering techniques. These high-resolution display techniques are used for CT angiography and venography, craniofacial and spinal imaging for surgical planning, and for stereotactic image guidance of radiotherapy, interventional, and neurosurgical procedures.
The role of CT has been redefined in the context of accessible and reliable US and MRI. 2 ± 4 US is the procedure of choice for primary imaging or screening of the brain and spinal neuraxis in the neonate and young infant. When US does not satisfy the clinical inquiry, or an acoustic window is not available, then CT becomes the primary modality for brain imaging in children, especially in acute or emergent presentations. This is especially important for acute neurologic presentations. In these situations, CT is primarily used to screen for acute or subacute hemorrhage (see Figure 2) , edema (see Figure 3) , herniation, fractures, hypoxic±ischemic injury, focal infarction, hydrocephalus, tumor mass, or abnormal collection (e.g., pneumocephalus, abscess, empyema). Other primary indications for CT include the evaluation of bony or airspace abnormalities of the skull base, cranial vault, orbit, paranasal sinuses, facial bones, and the temporal bone. Additionally, CT is the definitive procedure for detection and confirmation of calcification. It is also important in the bony evaluation of a localized spinal column abnormality (e.g., trauma). Contraindications to CT in childhood are unusual, particularly with the proper application of radiation protection, the appropriate use of nonionic contrast agents, the proper administration of sedation or anesthesia, and the use of vital monitoring.
When CT is used, intravenous enhancement for blood pool effect (e.g., CT angiography) or blood±brain barrier disruption is additionally recommended for the evaluation of suspected or known vascular malformation, infarction, neoplasm, abscess, or empyema. 2 ± 4 Enhanced CT may help evaluate a mass or hemorrhage of unknown etiology and identify the membrane of a chronic subdural collection (e.g., child abuse). By identifying the cortical veins, enhanced CT may distinguish prominent low-density subarachnoid NM involves imaging of the biologic distributions of administered radioactive pharmaceuticals. Whereas positron emission tomography (PET) has the unique ability to provide specific metabolic tracers (e.g., oxygen utilization and glucose metabolism) the wider availability, relative simplicity, and rapid technical advancement of single photon emission computed tomography (SPECT) allows more practical functional assessment of the pediatric CNS. Clinical and investigative applications of these technologies at this time include the assessment of brain development and maturation, focus localization in refractory childhood epilepsy (e.g., ictal perfusion SPECT, interictal PET), assessment of tumor progression versus treatment effects in childhood CNS neoplasia (perfusion and thallium SPECT, 18FDG-PET), the evaluation of occlusive cerebrovascular disease for surgical revascularization (e.g., perfusion SPECT), the diagnosis of brain death (perfusion SPECT), the use of brain-activation techniques (e.g., perfusion SPECT, PET) in the elucidation of childhood cognitive disorders, the assessment of CSF kinetics (e.g., in hydrocephalus, CSF leaks), and spinal column screening (skeletal SPECT). Magnetic resonance imaging (MR, MRI) is both a structural and functional imaging modality. 2 ± 4 MRI uses magnetic fields and radio waves. It is one of the less invasive or relatively noninvasive imaging technologies. Furthermore the MRI signal is exponentially derived from multiple parameters (e.g., T1, T2, proton density, T2*, proton flow, proton relaxation enhancement, chemical shift, magnetization transfer, and molecular diffusion) (Figures 4±14). MRI also employs many more basic imaging techniques than other modalities (e.g., spin echo, inversion recovery, gradient echo, and chemical shift imaging methods). Advancing MRI capabilities have further improved its sensitivity, specificity, and efficiency. 2 ± 4 These include the fluid attenuation inversion recovery technique (FLAIR), fat suppression short TI inversion recovery imaging (STIR), and magnetization transfer imaging (MTI) for increased structural resolution. Fast and ultrafast MRI techniques (fast spin echo, fast gradient echo, echo planar imaging) have also been developed to reduce imaging times, improve structural resolution, and provide functional resolution. Important applications include MR vascular imaging (MR angiography and venography Ð MRA) and perfusion MRI, diffusion imaging (DI), CSF flow and brain/cord motion imaging, brain activation techniques, and MR spectroscopy (MRS). Fast and ultrafast imaging techniques are also being used for fetal/obstetrical imaging, morphometrics, treatment planning, and``real-time'' MRI guided surgical and interventional procedures.
Although, in general, MRI is more expensive than US or CT, it is less expensive than the more invasive modalities such as angiography, which more often requires anesthesia. The role of MRI in imaging of the developing CNS is defined by its superior sensitivity and specificity in a number of areas compared to US and CT. 1 ± 4,6 MRI has also redefined the roles of invasive procedures like myelography, ventriculography, cisternography, and angiography. MRI provides multiplanar imaging with equivalent resolution in all planes without repositioning the patient. Bone does not interfere with soft-tissue resolution, although metallic objects often produce signal void or field-distortion artifacts. Some ferromagnetic or electronic devices (e.g., ferrous aneurysm clips and pacemakers) pose a hazard, and MRI is usually contraindicated in these cases. MRI is not as fast as US or CT, and patient sedation or anesthesia is often required in most infants and younger children, because image quality is easily compromised by motion. MRI may not be as readily accessible to the pediatric patient as is US or CT and may not be feasible in emergencies or for intensive care cases unless magnet-compatible vital monitoring and support is available. This is particularly important for the neonate.
MRI demonstrates superior sensitivity and specificity in a number of circumstances, particularly with the addition of new structural and functional techniques such as FLAIR, STIR, MTC, DI, PMRI, and MRS. 2 ± 4 The FLAIR sequence attenuates the signal from flowing water (i.e., CSF) and increases the conspicuity of nonfluid water containing lesions lying in close approximation to the CSF filled subarachnoid and ventricular spaces (see Figures 5 and 7) . The STIR technique suppresses fat signal to provide improved conspicuity of water containing lesions in regions where fat dominates (e.g., orbit, head and neck, spine). The MTI method suppresses background tissues and increases conspicuity for vascular flow enhancement (e.g., MRA) and gadolinium enhancement. MRI is the imaging modality of choice in a number of clinical situations.
± 4
These include developmental delay (e.g., static encephalopathy versus neurodegenerative disease); unexplained seizures (especially focal), unexplained neuroendocrine disorder, or unexplained hydrocephalus; the pretreatment evaluation of neoplastic processes and the follow-up of tumor response and treatment effects; suspected infectious, postinfectious, and other inflammatory or noninflammatory encephalitides (e.g., encephalitis, postinfectious demyelination, vasculitis); migrational and other submacroscopic dysgeneses (e.g., cortical dysplasia); neurocutaneous syndromes (e.g., neurofibromatosis 1, tuberous sclerosis); intractable or refractory epilepsy; vascular diseases, hemorrhage, and the sequelae of trauma.
MRI frequently offers greater diagnostic specificity than does CT or US for delineating vascular and hemorrhagic processes. This includes the clear depiction of vascular structures and abnormalities based on proton flow parameters and software enhancements not requiring the Using gradient recalled echo (GRE, GE) magnetic susceptibility sequences, MRI also provides more specific identification and staging of hemorrhage and clot formation according to the evolution of hemoglobin breakdown. MRI is often reserved for more definitive evaluation of hemorrhage and as an indicator or guide for angiography in a number of special situations. MRI may be used to evaluate an atypical or unexplained intracranial hemorrhage by distinguishing hemorrhagic infarction from hematoma and by distinguishing among the types of vascular malformations (e.g., cavernous malformation versus AVM). MRA may obviate the need in some cases of vascular malformation for conventional angiography in the follow-up of surgery, interventional treatment, or radiosurgery.
In the evaluation of intracranial vascular anomalies (e.g., vascular malformation, aneurysm), MRI may identify otherwise unsuspected prior hemorrhage (i.e., hemosiderin).
When CT demonstrates a nonspecific focal high density (calcification versus hemorrhage), MRI may provide further specificity, for example, by distinguishing an occult vascular malformation (e.g., cavernous malformation) from a neoplasm (e.g., glioma).It may further assist US or CT in differentiating benign infantile collections (i.e., external hydrocephalus) from subdural hematomas (e.g., in child abuse). MRI often also provides definitive evaluation of muscular and cutaneous vascular anomalies (i.e., hemangiomas, vascular malformations) that arise in parameningeal locations (e.g., head and neck, paraspinal) and extend to involve the CNS directly or are associated with other CNS vascular or nonvascular abnormalities.
MRS offers a noninvasive in vivo approach to biochemical analysis.
± 4,14 ± 19
Furthermore, MRS provides additional quantitative information regarding cellular metabolites because signal intensity is linearly related to steady-state metabolite concentration. MRS can detect cellular biochemical changes before the detection of morphologic changes by MRI or other imaging modalities. MRS may Figure 8 . MRI in term combined partial prolonged and profound HIE / HIRE with chronic cystic encephalomalacia. T2 image shows bilateral extensive septated hyperintense cysts, or cavities, of the cerebral hemispheres (small arrows ) along with abnormal basal ganglia and thalamic hypointensities (large arrows ). Figure 9 . MRS in a term newborn with acute± subacute HIE / HIRE. The spectrum shows an abnormally elevated and inverted lactate doublet peak ( L), a diminished NAA peak ( N) , elevated glutamate/glutamine peak ( G ), and normal creatine (Cr ) , choline ( Ch ), and myoinositol (I ) peaks.
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Neuroimaging of Fetal and Neonatal Brain Injury therefore provide further insight into both follow-up assessment and prognosis. With recent advances in instrumentation and methodology, and utilizing the high inherent sensitivity of hydrogen-1, single-voxel and multivoxel proton MRS is now carried out with relatively short acquisitions to detect low-concentration metabolites in healthy and diseased tissues. Phosphorus-31 spectroscopy has also been developed for pediatric use. Currently, MRS has been primarily used in the assessment of brain development and maturation, perinatal brain injury (see Figure 9 ), childhood CNS neoplasia versus treatment effects, and metabolic and neurodegenerative disorders. PMRI is currently being used to evaluate cerebral perfusion dynamics through the application of a dynamic contrast-enhanced T2*-weighted MR imaging technique. 2 ± 4,20 This new technique is undergoing further development to qualitate and quantitate normal and abnormal cerebrovascular dynamics of the developing brain by analyzing hemodynamic parameters including relative cerebral blood volume, relative cerebral blood flow, and mean transit time, all as complementary to conventional MR imaging. It is of limited utilization in the neonatal period because of venous access and safety issues. Current and advanced applications of this and other PMRI techniques not requiring contrast administration (e.g., flowactivated inversion recovery Ð FAIR, blood oxygen level determination Ð BOLD) include the evaluation of ischemic cerebrovascular disease (e.g., hypoxia±ischemia, moyamoya, sickle cell disease), the differentiation of tumor progression from treatment effects, and brain activation imaging,.
± 4
One of the most active areas of research is the localization of brain activity, an area previously dominated by NM including single photon emission computed 
tomography (SPECT) and positron emission tomography (PET).
Functional MRI (fMRI) is the terminology often applied to brain activation imaging in which local or regional changes in cerebral blood flow are displayed that accompany stimulation or activation of sensory (e.g., visual, auditory, somatosensory), motor, or cognitive centers. 2 ± 4 fMRI is providing important information regarding the spatial distribution of motor and cognitive function and functional impairment ( Figure 10 ). Also, it may serve as a guide for safer and more effective interventions including microneurosurgery or conformal radiotherapy, for example, the ablation of tumors, vascular malformations, and seizure foci.
Using echo planar or line-scan spin echo techniques, diffusion imaging (DI) provides information based upon differences in the rate of diffusion of water molecules and is especially sensitive to intracellular changes.
± 4,21 ± 27
The rate of diffusion, or apparent diffusion coefficient (ADC), is higher for free or pure water than for macromolecular bound water. The ADC varies according to the microstructural or physiologic state of a tissue. Current clinical applications include the assessment of brain maturation, the evaluation of acute ischemic injury (see Figures 4 and 7) , and the analysis of the sequelae of injury (see Figure 10) . A particularly important application of DI is in the early detection of diffuse and focal ischemic injury. The ADC of water is reduced within minutes of an ischemic insult and is progressive within the first hour. Abnormal signal is demonstrated on DI at a time when conventional imaging is negative and likely reflects cellular injury (e.g., necrosis). Further investigation is underway regarding the roles of DI, PMRI, and MRS in the early diagnosis and treatment of potentially reversible ischemic injury. Motion sensitive MRI techniques are not only used to evaluate vascular flow (e.g., MRA) and perfusion, but may also be used to demonstrate the effect of pulsatile cardiovascular flow on other fluid tissues (e.g., CSF) and on nonfluid tissues such as the brain and spinal cord. Using cardiac or pulse gating, these MRI techniques may be used to evaluate, preoperatively and postoperatively, abnormalities of CSF dynamics (e.g., hydrocephalus, hydrosyringomyelia), as well as abnormalities of brain motion (e.g., Chiari malformation), and spinal cord motion (e.g., tethered cord syndrome).
± 4

GUIDELINES AND PRINCIPLES OF IMAGING DIAGNOSIS Developmental Abnormalities
Congenital abnormalities of the CNS may be developmental or acquired in origin and result from defective formation, postformational destruction, or disordered maturation.
± 4,28 ± 34
These are probably best classified according to gestational timing (Table 1) Figure 12 . MRI of a young infant with diffuse cortical dysgenesis associated with early gestational cytomegaloviral infection. T2 image shows a bilaterally serrated, hypointense cortical ribbon consistent with polymicrogyria ( arrows ) along with ventriculomegaly. Figure 13 . MRI of kernicterus in a young infant. T2 image shows bilateral globus pallidus hyperintensities ( arrows ).
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Neuroimaging of Fetal and Neonatal Brain Injury and include disorders of dorsal and ventral neural tube formation; disorders of neural, glial, and mesenchymal formation; neuroclastic processes (i.e., encephaloclastic, myeloclastic); and disorders of maturation (i.e., myelination and cortical maturation). Developmental anomalies readily identified by US (prenatal or postnatal) or CT are the gross formational macrostructural defects of categories I±IV and the gross neuroclastic macrostructural lesions of category V (Table 1) . 2 ± 4,34 This is especially true for those abnormalities involving the ventricular system or containing CSF. These include hydrocephalus, hydranencephaly, holoprosencephaly, absent septum pellucidum, agenesis of the corpus callosum, porencephaly, open schizencephaly, the Dandy±Walker±Blake spectrum, arachnoid cysts, and cephaloceles. US may not clearly distinguish between hydranencephaly (absent cerebral mantle) and severe hydrocephalus (attenuated cerebral mantle). Other gross macrostructural anomalies often delineated by US or CT include Chiari II malformation, lissencephaly, and vascular malformations such as the Galenic malformation. In fact, any lesion detected by US, particularly a cystic one, should be examined with Doppler to determine if it is vascular in nature. Neuroclastic processes are those destructive lesions of the already formed CNS and may result from a variety of prenatal or perinatal insults including hypoxia±ischemia and infection (Table 1) . 2 ± 4,34 MRI may occasionally demonstrate subtle macrostructural abnormalities not revealed by US or CT (e.g., periventricular leukomalacia).
MRI is important when the US or CT fails to satisfy the clinical investigation. MRI often provides a more complete delineation of complex macrostructural CNS anomalies for diagnosis, treatment, prognosis, and genetic counseling. 2 ± 4,34 In fact, ultrafast MRI techniques are being increasingly used prenatally to evaluate for fetal CNS abnormalities in at-risk pregnancies or as detected by obstetrical US (Figure 11 ).
± 4,35 ± 38
Furthermore, MRI is often indicated if more specific treatment is planned beyond simple shunting of hydrocephalus. Intraoperative guidance may be provided by real time and Doppler US. Patients with craniosynostosis are initially evaluated with plain films. Those with multiple suture involvement, especially when associated with craniofacial syndromes, often require more extensive evaluation including three-dimensional CT, CT venography, MRI, and MR venography (jugular venous stenoocclusive disease with collateralization). MRI is often required to structurally delineate the more subtle macrostructural anomalies arising as disorders of migration and cortical organization (category III Ð Figure 12 ) or as disorders of proliferation, differentiation, and histiogenesis (category IV).
± 4,34
The perfusional and metabolic characteristics of these anomalies (e.g., focal cortical dysgenesis, hemimegalencephaly) may be investigated with SPECT and PET, respectively, in children with medically refractory partial epilepsy who are candidates for surgical ablation. For added precision, the SPECT or PET data may be fused with the MRI data to provide a higher resolution spatial display of the functional information. MRS, DI, and PMRI with fMRI are also contributing to the evaluation and treatment of these patients. MRI is now the preferred modality for the screening and definitive evaluation of the dysgenetic, neoplastic, and vascular manifestations of the neurocutaneous syndromes. After initial screening with US or CT, MRI is also considered the primary technology for treatment planning and follow-up of vascular malformations and developmental tumors.
± 4
Although arachnoid cysts are often readily delineated by US or CT, MRI may be necessary for confirmation (i.e., to exclude solid tumor) and for surgical planning. FLAIR or DI may readily distinguish an arachnoid cyst from other lesions (e.g., dermoid±epidermoid, fibrillary astrocytoma). Maturation (i.e., myelination and cortical maturation) and disorders of maturation (category VI) may be precisely assessed only by MRI.
± 4,39 ± 41
The MRI findings, however, are often nonspecific regarding causation particularly in the first year of life because of the watery character of the immature brain. MRS may add specificity to the diagnostic evaluation of these infants.
Neurovascular Disease
Neurovascular disease characteristically presents as an acute neurologic event. However, a recently discovered but fixed deficit (e.g., hemiplegia, spastic diplegia, hypotonia) may be the first indication of a remote prenatal or perinatal neurovascular injury. Imaging assists in the clinical evaluation and differentiation of hypoxia±ischemia, hemorrhage, and occlusive vascular disease (Tables 2±4). 1 ± 4,6
Hypoxic±ischemic injury and sequelae. In general, the pattern of injury associated with hypoxic±ischemic±reperfusion encephalo- Figure 14 . Diffusion MRI of a term newborn with congenital heart disease and multifocal embolic cerebral infarction. ADC map shows multiple abnormal hypointense foci (restricted diffusion ) within arterial distributions (arrows ).
pathy (HIE/HIRE), or other insults, varies with severity and duration of the insult as well as with the gestational age (GA) of the fetus or infant at the time of the insult ( Table 2 ).
1 ± 4,6,12,42 ± 52 Different brain structures are more vulnerable than others to the different types of HIE/HIRE insults (e.g., partial prolonged, profound, combined) at different stages of brain development (e.g., formational versus postformational GA, preterm versus term versus full term versus postterm GA). Brain tissues in the arterial borderzones or watersheds, brain tissues with high metabolic demands, mature or actively maturing tissues, and tissues with higher concentrations of neuroexcitatory amino acids, are particularly vulnerable to HIE/ HIRE and to other insults (e.g., hypoglycemia, trauma, infection, seizures).
± 4,6,27,52
Prenatal or perinatal partial prolonged HIE/HIRE (e.g., one or more insults of hypoxia/hypoperfusion) may be associated with periventricular borderzone/watershed injury to the preterm fetus or neonate (e.g., 27±35 weeks GA Ð see Figures 4  and 5) , or cortical and subcortical border zone/watershed cerebral injury during term gestation (e.g., 37±42 weeks GA Ð see Figure  6 ). A combined partial prolonged HIE/HIRE pattern (cortical/ subcortical/periventricular) may be seen in the late preterm to the early midterm GA (e.g., 36±39 weeks). Fetal or neonatal brain injury may also occur with more profound HIE/HIRE insults (e.g., anoxia or circulatory arrest) and involve the thalami, basal ganglia (especially putamina), brain stem (especially midbrain), hippocampi, paraventricular white matter, and perirolandic cortex (see Figure 7 ). This type of injury may also vary with GA (thalamic greater than putaminal involvement in the preterm GA; putaminal, hippocampal, and paracentral injury more common in the term GA). Combined patterns (i.e., partial prolonged plus profound HIE/ HIRE) are also common (see Figure 8 ). There may be subarachnoid hemorrhage, germinal matrix and intraventricular hemorrhage (e.g., premature fetus or neonate), choroid plexus/intraventricular hemorrhage (e.g., term fetus or neonate), or intracerebral hemorrhage (e.g., hemorrhagic infarction). The hemorrhage usually appears hyperechoic on US and high density on CT in the acute to subacute phases (range 3 hours to 7 days) unless there is associated coagulopathy (see Figure 2) . With evolution and resolution, the hemorrhage becomes isoechoic to hypoechoic and isodense to low density. MRI may offer more specific characterization of the hemorrhagic component with regard to timing ( Table 3 ). The edema (range 1±5 days) of nonhemorhagic HIE/HIRE often peaks between 2 and 4 days after the insult(s).
1 ± 4,6,12,27,42 ± 52 US may show hyperechogenicity (see Figure 1) , CT may show hypodensities with decreased gray±white matter differentiation (see Figure 3) . In the early phases of the injury, the neuroimaging findings are often nonspecific as to specific causation (e.g., HIE/HIRE versus infection versus metabolic disorder).
± 4,6,52
MRI or US may provide greater sensitivity and specificity depending upon the techniques used and the timing of the imaging (see Figures 1±9) . Conventional MRI may show characteristic T1-hypointensities/T2-hyperintensities (12±48 hours), followed by 
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Neuroimaging of Fetal and Neonatal Brain Injury T1-hyperintensities (about 3 days), and then T2 hypointensities (about 6 days). 45 DI may be abnormal before conventional MRI and show restricted diffusion with decreased ADC as increased intensity on diffusion images and decreased intensity on ADC maps (see Figures 4  and 7 ).
± 4,21 ± 27
Doppler with resistive indices (e.g., RI <60) or MRS (e.g., elevated lactate, elevated glutamate, elevated lipids, decreased N-acetylaspartate Ð NAA) may provide additional early indicators of timing and outcome (see Figures 1 and 9 ). 1 ± 11,14 ± 19,53 The more subtle ischemic PVL lesions (e.g., cystic phase) are occasionally better delineated by US [2±6 weeks after insult(s)] than by CT or MRI, in which the density and intensity character of immature white matter often obscures the injury. However, CT and MRI often show gray matter injury better than US. 1 ± 4,6 ± 8 Further developments of PMRI, DI, and MRS may further improve diagnostic sensitivity and specificity. In fact, DI has demonstrated restricted diffusion in the acute phase of PVL when US, CT, and conventional MRI were negative or nonspecific (see Figure 4) . 47 Such advances may facilitate the early institution of neuroprotective measures to treat potentially reversible primary injury (necrosis, apoptosis) and secondary injury (transneural degeneration) in HIE/HIRE. 27 These advanced MRI techniques may also assist in distinguishing HIE/ HIRE from other causes of encephalopathy including other common metabolic disorders (e.g., hypoglycemia, hyperbilirubinemia Ð Figure 13 ), nonmetabolic conditions (e.g., infection), and other rarer disorders (e.g., inborn metabolic errors).
The long-term result of HIE/HIRE is a static encephalopathy (i.e., CP) and imaging may demonstrate injury in the chronic phases [ >14±21 days after the insult(s) ] including porencephaly, hydranencephaly, atrophy, chronic periventricular leukomalacia, cystic encephalomalacia, gliosis, or mineralization in a characteristic distribution as described above (see Figures 5±8) . 1 ± 4,6,12,27,42 ± 52 The chronic changes are best demonstrated by CT or MRI. In general, for pattern of injury and timing purposes, two pieces of imaging evidence are optimally desired: (1) late imaging, and preferably MRI, beyond 2±3 years of age when the brain is greater than 90% mature (no more water of immaturity) to get a final, permanent injury pattern for causative etiology and GA timing, and (2) early postnatal (and/or prenatal) serial imaging to evaluate evolution in the acute, subacute, and chronic phases so that timing as to``day range'' relative to the perinatal and peripartum periods may be assessed.
Intracranial hemorrhage and sequelae. Intracranial hemorrhage may result from parturitional trauma (see Figure 2) , HIE/HIRE, a coagulopathy (e.g., thrombocytopenia, disseminated intravascular coagulopathy Ð DIC, extracorporal membrane oxygenation Ð ECMO), vasoocclusive disease (e.g., venous thrombosis), or may be idiopathic.
1 ± 4,6 ± 8,52,54 ± 57 Hemorrhage may occasionally be associated with infection (e.g., herpes simplex virus 2). Vascular malformations producing intracranial hemorrhage are rare in the neonate and young infant and usually not encountered until later childhood (i.e., arteriovenous malformationsÐ AVM, cavernous malformations, developmental venous anomalies, and telangiectasias). 1 ± 4,54,57 Aneurysms are exceedingly rare in children but may be developmental, associated with a syndrome (e.g., Turner syndrome), or related to trauma (e.g., dissection) or infection (i.e., mycotic aneurysm). The vein of Galen malformations are subclassified as choroidal, mural, and AVM types. They rarely hemorrhage and more commonly present in infancy with congestive heart failure, cerebral ischemia, or hydrocephalus. 57 US or CT remains the primary imaging choice in acute situations 1 ± 4,6 ± 8,52,56 and the imaging findings are described in the previous section (see Figure 2) . Acute intracranial hemorrhage, particularly subarachnoid, is most specifically diagnosed by CT and lumbar puncture for CSF analysis. Although FLAIR may identify subarachnoid hemorrhage as hyperintensity and GRE/GE may identify acute hemorrhage in any location as hypointensity, MRI often provides better specificity beyond the acute phases (Table 3) . Hemorrhagic manifestations and sequelae of HIE/HIRE in the premature infant readily detected by US include germinal matrix hemorrhage, intraventricular hemorrhage, periventricular hemorrhagic infarction, and posthemorrhagic hydrocephalus. 56 Choroid plexus hemorrhage and hemorrhagic infarction in the term infant are also easily demonstrated. Portable US may effectively delineate the potential hemorrhagic or ischemic sequelae of ECMO. Although CT has been more reliable, high resolution US using transfontanelle and transcranial approaches, including the mastoid view, may now accurately detect extracerebral hemorrhage (subdural and subarachnoid) and posterior fossa collections (cerebellar or subdural). Color Doppler US, MRA, and CTA are all able to identify and distinguish the types of Galenic malformations, and provide followup. Angiography is more specifically directed to the definitive interventional or surgical management of these and other vascular anomalies. 57 Real-time, Doppler US provides intraprocedural guidance and monitoring. The long-term sequelae of intracranial hemorrhage are best demonstrated by CT and MRI (e.g., hydrocephalus, atrophy, encephalomalacia, porencephaly, calcification, hemosiderin).
Occlusive neurovascular disease and sequelae. Occlusive neurovascular disease in the child may be arterial or venous in origin and typically results in focal or multifocal lesions within the distribution of the occluded vessel or vessels (Table 4) . 1 ± 4,6,52 ± 55 Arterial occlusive disease may be partial or complete and due to stenosis, thrombosis, or embolization. The result may be ischemic infarction or hemorrhagic infarction followed by atrophy. Arterial occlusive disease may occur as a prenatal or perinatal event (emboli of placental origin, fetal heart, or involuting fetal vessels), as a complication of infection (e.g., meningitis), with congenital heart disease ( Figure 14) , or from a hypercoagulopathy. Other causes include trauma (e.g., dissection), arteriopathies (e.g., moyamoya), and metabolic disorders (e.g., mitochondrial cytopathies). Conditions commonly associated with cortical or dural venous sinus occlusive disease include infection, dehydration, perinatal encepha-lopathy, cyanotic congenital heart disease, polycythemia, other hypercoagulable states, DIC, and trauma. Color Doppler US may be used as a noninvasive tool for initial identification and monitoring of these infants. MRI may be more sensitive and specific than US or CT for ischemic infarction, hemorrhagic infarction, and venous thrombosis. 7, 8 MRA or CTA may also contribute to the diagnosis of arterial or venous occlusion and clarify the need for cerebral angiography, particularly when anticoagulation or thrombolysis is being considered. As mentioned above, PMRI, DI, and MRS are contributing to the early diagnosis and timely treatment of ischemic insults. The long-term sequelae of infarction include atrophy, encephalomalacia, gliosis, mineralization, and porencephaly. These are readily shown by follow-up CT or MRI.
Acute myelopathy due to HIE/HIRE, vascular occlusion, hemorrhage, or vascular malformation is extremely rare in the perinatal period. Spinal MRI is the definitive procedure to evaluate spinal cord infarction or hemorrhage (see section on Trauma). Spinal angiography is necessary to evaluate for vascular malformation in anticipation of interventional or surgical therapy.
± 4
Trauma With improvements in resolution and the use of additional views (e.g., mastoid view), US may be used as the primary modality for evaluating the newborn with parturitional trauma. CT, however, is usually relied upon for delineating scalp and skull injury, extracerebral hemorrhage (e.g., subarachnoid or subdural hemorrhage Ð see Figure 2 ), posterior fossa hemorrhage, and direct (e.g., contusion) versus indirect (e.g., HIE/HIRE) brain injury.
1 ± 4,6,52,58 ± 62 CT is sufficiently sensitive and specific for acute hemorrhage and the complications or sequelae of fractures (e.g., growing fracture, leptomeningeal cyst). Occasionally, skull films will demonstrate a skull fracture not shown by CT. MRI is often reserved for circumstances in which neurologic deficits persist and the CT is negative or nonspecific. In this situation MRI may reveal lesions such as brain stem infarction, diffuse axonal (shear) injury, and cortical contusion, or sequelae such as gliosis, microcystic encephalomalacia, and hemosiderin deposition. MRI is often more specific than CT for hemorrhage beyond the hyperacute/ acute stage (Table 3) . Color Doppler US, contrast-enhanced CT, or MRI may distinguish external hydrocephalus (dilated subarachnoid spaces) from chronic subdural hematomas (e.g., in child abuse) when nonenhanced CT demonstrates nonspecific extracerebral collections. 2 ± 4,10,11 Furthermore, hemosiderin as demonstrated by MRI is confirmation of a previous hemorrhage. In children with atypical intracranial hemorrhage (hemorrhage out of proportion to the history of trauma), MRI may detect an existing vascular malformation, show a hemorrhagic neoplasm, or suggest child abuse (e.g., interhemispheric subdural hematoma, hemorrhages of different age).
Initial evaluation of spine trauma (e.g., fracture/dislocation) may include plain films, US, CT (including reformatting), or rarely SPECT. Radiologic abnormality, changing clinical signs, or signs not explained by brain imaging may provide the indication for spinal MRI.
An existing spinal anomaly or mass should be ruled out. MRI is the procedure of choice to demonstrate acute spinal injury (e.g., intraspinal hemorrhage, cord contusion, cord edema, transection, brachial plexus injury, ligamentous injury, etc.) and the sequelae of spinal injury (e.g., hydrosyringomyelia, cystic myelopathy, myelomalacia, etc.).
Infections and Inflammatory Processes
US or CT is often used to delineate CNS infection and the sequelae or complications that may accompany TORCH (i.e., toxoplasmosis, other [e.g., syphilis], rubella, cytomegalovirus Ð CMV, herpes simplex virus Ð HSV2, human immunodeficiency virus Ð HIV) causes of meningoencephalitis, and neonatal meningitis (e.g., group The imaging pattern is often asymmetric and progressive. Such findings include subarachnoid exudate, ventriculitis, edema, cerebritis, infarction, hydrocephalus, effusion, empyema, abscess, cystic encephalomalacia, atrophy, gliosis, and calcification. In the absence or nonspecificity of findings on US or CT, MRI may provide more definitive evaluation (e.g., CMV Ð Figure 12) . CT or MRI with intravenous contrast enhancement may also be preferred for the diagnosis and follow-up of suppurative collections. Less common but increasingly prevalent causes of subacute and chronic CNS inflammation are the granulomatous meningoencephalitic infections (e.g., tuberculosis, spirochete, fungal, parasitic), particularly in immunocompromised hosts.
Recurrent infectious or noninfectious CNS infection (e.g., meningitis) may require investigation for a``parameningeal focus'' (e.g., sinus or mastoid infection, dermal sinus, primitive neurenteric connection, CSF leak after trauma, dermoid±epidermoid). 63 Brain abscess or empyema may be associated with Gram-negative meningitis (e.g., citrobacter) in the neonate. Suppurative collections related to sinus infection, trauma, surgery, sepsis, the immunocompromised state, or uncorrected cyanotic congenital heart disease primarily occur in older children. Contrast-enhanced CT usually suffices for diagnosis and follow-up. Occasionally, multiplanar T2-MRI or gadolinium-enhanced T1-MRI is needed to delineate subtle collections for drainage. Contrast-enhanced stereotactic CT or intraoperative US may provide direct guidance.
Plain films or SPECT are recommended for screening of suspected spinal column infection (discitis, osteomyelitis). 2 ± 4 CT and MRI are often needed, however, for definitive diagnosis, treatment planning, and follow-up. MR is the procedure of choice for evaluating spinal neuraxis infection and gadolinium enhancement is particularly important for demonstrating suppurative collections (e.g., epidural abscess).
Metabolic Disorders
Particularly in the evaluation of developmental delay (e.g., static encephalopathy versus progressive encephalopathy), MRI is the only modality that can provide an accurate assessment of brain maturation based on myelination and cortical development.
± 4,66 ± 74
The clinical hallmark of a metabolic, toxic, or neurodegenerative disorder is progressive neurologic impairment in the absence of a CNS tumor or another readily identifiable process (e.g., infection). These disorders may be exogenous and internal (e.g., hypoglycemia, hyperbilirubinemia Ð see Figure 13 ) or external (e.g., fetal alcohol syndrome). The endogenous disorders (e.g., inborn errors of metabolism) are rare and often untreatable. Many are genetic and heredofamilial disorders such that genetic counseling and prenatal screening are important when possible. Diagnosis is primarily a clinical one and may involve metabolic testing (e.g., enzymatic assays), genetic evaluation, or biopsy of CNS or extra-CNS tissues. MRI is superior to CT in evaluating disease extent and anatomic distribution. Occasionally MRI may demonstrate characteristic imaging findings (e.g., kernicturus Ð see Figure 13 , Zellweger disease). MRS contributes to the specific metabolic characterization of these disorders. 14 ± 19,53 Stereotactic CT or MRI may serve as a guide for biopsy.
The classification of metabolic diseases may be biochemical, molecular, genetic, pathologic, or clinical. 2 ± 4,66 ± 74 These disorders are often categorized according to the metabolic defect. Such a classification includes the lysosomal disorders (e.g., Krabbe), peroxisomal defects (e.g., Zellweger), the mitochondrial disorders (e.g., Leigh, Menkes), organic and amino acidopathies (e.g., nonketotic hyperglycinemia), disorders of carbohydrate metabolism (e.g., glycogen storage disease), liver metabolic disorders, and miscellaneous. Certain clinical features that assist in directing the initial evaluation of these patients may also provide a basis for classification (e.g., macrocephaly in maple syrup urine disease). The ideal radiologic classification would categorize the diseases by the anatomic distribution of the pathologic process using CT and MRI.
Unfortunately, most of these conditions affect multiple sites and considerable overlap in appearance is found. However, a practical imaging classification may be based on the predominant areas of involvement including the white matter (subcortical, periventricular), gray matter (cortical, deep), basal ganglia, brain stem, cerebellum, spinal cord, and peripheral nervous system.
Disorders primarily affecting cortical gray matter. Endogenous metabolic disorders that primarily, or predominately, affect the cortical gray matter include the storage diseases that result from lysosomal enzyme defects. 2 ± 4,66 ± 74 However, these findings are often nonspecific and the differential diagnosis may include diffuse cortical atrophy due to any number of causes. Other considerations include the end-stage of a static encephalopathy (e.g., post-HIE/HIRE or postinfection), or``atrophy'' related to chronic systemic disease, malnutrition, or certain types of therapy (e.g., steroids, chemotherapy, radiation, anticonvulsants).
Disorder primarily affecting deep gray matter. Metabolic disorders may primarily involve the deep gray matter (including mineralization).
Those disorders primarily involving the corpus striatum (i.e., caudate and putamen) include the mitochondrial disorders, organic and amino acidopathies, juvenile Huntington's disease, Wilson disease, and Cockayne's syndrome. Those disorders primarily involving the globus pallidus include Hallervorden±Spatz disease, the aminoacidopathies, hyperbilirubinemia (see Figure 13) , and toxic exposure (e.g., carbon dioxide). It is unusual to see isolated involvement of the thalami in any of the metabolic disorders. However, thalamic involvement may be an early or dominant feature of Krabbe disease or GM2 gangliosidosis. It may also be seen in the infantile form of Leigh disease along with extensive brain stem, basal ganglia, and cerebral white matter involvement. In general, the differential diagnosis, depending on the clinical picture and timing of the imaging, may also include profound HIE/HIRE, hypoglycemia, toxic exposure (e.g., methane, cyanide), osmolar myelinolysis, striatal necrosis, and meningoencephalitis (e.g., mycoplasma).
Disorders primarily affecting white matter. Those disorders that primarily, or predominately, affect the white matter are known as the leukoencephalopathies. 2 ± 4,66 ± 74 Traditionally, leukoencephalopathies have been divided into dysmyelinating and myelinoclastic disorders. In dysmyelinating disorders an intrinsic (inherited) enzyme deficiency results in the disturbed formation, destruction, or turnover of the essential components of myelin. They are also referred to as the leukodystrophies. The pattern of damage is symmetrical in both hemispheres, has diffuse margins, often spares the arcuate fibers, and consistently involves the cerebellar white matter. The leukodystrophies are primarily associated with the lysosomal and peroxisomal disorders (e.g., metachromatic leukodystrophy, Krabbe leukodystrophy, and the adrenoleukodystrophy complex), and with diseases of white matter (e.g., Pelizaeus±Merzbacher, Canavan, Alexander, and Cockayne). Included in the differential diagnosis is infantile-onset leukoencephalopathy with swelling (macrocephaly) and mild clinical course. The lack of myelination (hypomyelination) may suggest Pelizaeus±Merzbacher disease or Menkes' disease.
In myelinoclastic disorders, the myelin sheath is intrinsically normal until it yields to exogenous or endogenous myelinotoxic factors. The pattern of damage is asymmetric, is sharply demarcated, irregularly involves the subcortical arcuate fibers, and may spare the cerebellum. Examples are the infectious demyelinating diseases (e.g., TORCH, HIV, SSPE), postinfectious encephalitides (ADEM), and the vasculitidies.
Disorders affecting both white matter and cortical gray matter. A number of metabolic disorders involve both gray and white matter. 2 ± 4,66 ± 74 Those disorders associated with cortical atrophy along with white matter involvement include lysosomal disorders such as the lipidoses and mucopolysaccharidoses (also, associated skeletal dysplasia), and mitochondrial disorders such as Alper disease and Menkes' disease. If there is a diffuse cortical dysgenesis (e.g., lissencephaly, polymicrogyria) associated with white matter abnormalities, then peroxisomal disorders such as Zellweger syndrome should be considered along with congenital infections (e.g., cytomegaloviral), and the congenital muscular dystrophies (e.g., Fukuyama, Walker±Warburg, Santavuori).
Disorders affecting both white matter and deep gray matter. Disorders associated with deep gray matter involvement, in addition to white matter abnormalities, include those with primarily corpus striatum involvement (Leigh, MELAS, Wilson's, Cockayne's), those with predominant thalamic abnormalities (Krabbe, GM2 gangliosidoses), and those with primarily globus pallidus involvement (Canavan, maple syrup urine disease, methylmalonic/propionic acidopathy, Kearns±Sayre). 2 ± 4,66 ± 74 Also, included in the differential diagnoses, depending on the clinical context, are profound hypoxia±ischemia, osmolar myelinolysis, toxic exposure (e.g., carbon dioxide, methane, cyanide, radiation, chemotherapy), and infectious, or postinfectious, processes (e.g., TORCH, HIV, ADEM). Hydrogen-1 MRS is being increasingly used in patients with metabolic disorders. 2 ± 4,14 ± 19 Although many of the metabolic and neurodegenerative disorders have specific biochemical markers, most of the disorders have no differentiating features. Nonspecific MRS abnormalities are those that reflect brain destruction and reactive changes including delayed maturation, neuronal loss, axonal degeneration, demyelination, and gliosis. Alterations in metabolites are often displayed as a ratio relative to the reference metabolite, creatine (Cr), an energy marker. In disorders in which there is predominant neuronal degeneration (i.e., loss of cell bodies, axons) and atrophy, the major MRS finding is a decrease in NAA (see Figure 9 ), a neuronal (neurons including axons) and immature oligodendroglial marker. In disorders in which there is predominant loss of myelin sheaths with secondary axonal degeneration and gliosis (e.g., demyelination), the characteristic spectral abnormalities are characterized by elevated lipids, a marker for myelin destruction; elevated choline (Cho), a marker of membrane turnover (e.g., myelin, glial); variable increases in lactate (L), a marker of anaerobic glycolysis; elevated glutamate/ glutamine (G), neuroexcitatory amino acid markers; and, elevated myoinositols (M), also an osmolyte and glial marker. Associated neuronal (e.g., axonal) or immature oligodendroglial damage is indicated by a decrease in NAA. More specific MRS abnormalities may be seen in a number of disorders, for example, disorders of energy metabolism (predominant lactate elevation, e.g., hypoxia± ischemia Ð Figure 9 , mitochondrial disorder), phenylketonuria (increased phenylalanine peak at 7.37 ppm), maple syrup urine disease (abnormal peak at 0.9 ppm), nonketotic hyperglycinemia (elevated glycine peak at 3.55 ppm), Niemann±Pick disease (abnormal lipid peak at 1.2 ppm), and Canavan disease (increased NAA).
SUMMARY
US and CT may provide important screening information, particularly with regard to hemorrhage, trauma, hydrocephalus, infection, and gross macrostructural anomalies. However, current and advanced MRI techniques often provide more definitive macrostructural, microstructural, and functional imaging information in both the early and late assessment of fetal and neonatal CNS injuries.
